Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Resbeut

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Breast (Edinburgh, Scotland)|May 24, 2016
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosisRenaud Sabatier, Laura Sabiani, Christophe Zemmour, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2010
High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study)Jean-Michel Hannoun-Levi, Cécile Ortholan, Michel Resbeut, et al.
Journal of Applied Clinical Medical Physics|July 1, 2018
Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapyMarguerite Tyran, Agnes Tallet, Michel Resbeut, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)Cécile Ortholan, Michel Resbeut, Jean-Michel Hannoun-Levi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantationLaurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Bulletin Du Cancer|February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Journal of Cancer|November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective studyLaurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Bulletin Du Cancer|June 13, 2003
[Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)]Michel Resbeut, Eric Fondrinier, Béatrice Fervers, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Breast (Edinburgh, Scotland)|May 24, 2016
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosisRenaud Sabatier, Laura Sabiani, Christophe Zemmour, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2010
High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study)Jean-Michel Hannoun-Levi, Cécile Ortholan, Michel Resbeut, et al.
Journal of Applied Clinical Medical Physics|July 1, 2018
Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapyMarguerite Tyran, Agnes Tallet, Michel Resbeut, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)Cécile Ortholan, Michel Resbeut, Jean-Michel Hannoun-Levi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantationLaurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
BMC Surgery|November 17, 2016
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalEric Lambaudie, Gilles Houvenaeghel, Amira Ziouèche, et al.
Bulletin Du Cancer|February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Journal of Cancer|November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective studyLaurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Bulletin Du Cancer|June 13, 2003
[Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)]Michel Resbeut, Eric Fondrinier, Béatrice Fervers, et al.
Pageof 3